Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tony Butler is an analyst at Rodman & Renshaw. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | MURA | Buy Now | Mural Oncology | $3.14 | 377.71% | → $15 | Initiates | → Buy | Get Alert |
| 06/28/2024 | LPTX | Buy Now | Leap Therapeutics | $1.82 | 339.56% | → $8 | Initiates | → Buy | Get Alert |
| 08/10/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | IPSC | Buy Now | Century Therapeutics | $2.50 | 540% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | FATE | Buy Now | Fate Therapeutics | $3.28 | 204.88% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 38.53% | → $75 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2023 | GTBP | Buy Now | GT Biopharma | $2.68 | -25.37% | → $60 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | CGEN | Buy Now | Compugen | $1.78 | 630.34% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 543.78% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.55 | 143.31% | → $50 | Reiterates | → Buy | Get Alert |
| 08/03/2023 | ARAV | Buy Now | Aravive | — | — | — | Downgrade | Buy → Hold | Get Alert |
| 08/02/2023 | GTHX | Buy Now | G1 Therapeutics | $2.35 | 708.51% | → $19 | Reiterates | → Buy | Get Alert |
| 08/02/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | BMEA | Buy Now | Biomea Fusion | $4.57 | 840.92% | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2023 | PYXS | Buy Now | Pyxis Oncology | $3.30 | 354.55% | → $15 | Initiates | → Buy | Get Alert |
| 07/31/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.57 | 1651.93% | → $10 | Initiates | → Buy | Get Alert |
| 07/25/2023 | BMEA | Buy Now | Biomea Fusion | $4.57 | 840.92% | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/18/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | BMEA | Buy Now | Biomea Fusion | $4.57 | 840.92% | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | CVM | Buy Now | CEL-SCI | $1.16 | 762.07% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 07/07/2023 | CALC | Buy Now | CalciMedica | $3.92 | 333.67% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 07/03/2023 | AGEN | Buy Now | Agenus | $16.80 | -50.6% | → $166 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | SVA | Buy Now | Sernova | $5.85 | -14.53% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | CALC | Buy Now | CalciMedica | $3.92 | 333.67% | → $17 | Initiates | → Buy | Get Alert |
| 06/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 38.53% | → $75 | Reiterates | → Buy | Get Alert |
| 06/07/2023 | REPL | Buy Now | Replimune Group | $9.00 | 566.67% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | CGEN | Buy Now | Compugen | $1.78 | 630.34% | → $13 | Reiterates | → Buy | Get Alert |
| 06/05/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 543.78% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | AGEN | Buy Now | Agenus | $16.80 | -50.6% | → $166 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | INAB | Buy Now | IN8bio | $0.83 | 861.31% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | REPL | Buy Now | Replimune Group | $9.00 | 566.67% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | → Buy | Get Alert |
| 06/01/2023 | VNRX | Buy Now | VolitionRX | $0.60 | 891.74% | → $6 | Assumes | → Buy | Get Alert |
| 06/01/2023 | HCWB | Buy Now | HCW Biologics | $0.65 | 1291.04% | → $9 | Assumes | → Buy | Get Alert |
| 05/30/2023 | RAIN | Buy Now | Rain Oncology | — | — | $5 → $2 | Maintains | Hold | Get Alert |
| 05/26/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 543.78% | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | AGEN | Buy Now | Agenus | $16.80 | -50.6% | → $166 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | → Buy | Get Alert |
| 05/26/2023 | APGN | Buy Now | Apexigen | — | — | → $0.64 | Reiterates | Hold → Hold | Get Alert |
| 05/26/2023 | CGEN | Buy Now | Compugen | $1.78 | 630.34% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | REPL | Buy Now | Replimune Group | $9.00 | 566.67% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | AGEN | Buy Now | Agenus | $16.80 | -50.6% | → $166 | Assumes | → Buy | Get Alert |
| 05/25/2023 | OCEA | Buy Now | Ocean Biomedical | $1.24 | 1270.97% | → $17 | Assumes | Buy → Buy | Get Alert |
| 05/24/2023 | APGN | Buy Now | Apexigen | — | — | → $0.64 | Downgrade | Buy → Hold | Get Alert |
| 05/24/2023 | CGEN | Buy Now | Compugen | $1.78 | 630.34% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | — | — | $16 → $5 | Downgrade | Buy → Hold | Get Alert |
| 05/16/2023 | GTBP | Buy Now | GT Biopharma | $2.68 | -25.37% | → $60 | Reiterates | Hold → Hold | Get Alert |
| 05/16/2023 | APGN | Buy Now | Apexigen | — | — | $8 → $5 | Maintains | Buy | Get Alert |
| 05/12/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | SVA | Buy Now | Sernova | $5.85 | -14.53% | → $5 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.55 | 167.64% | → $55 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 543.78% | → $15 | Maintains | Buy | Get Alert |
| 04/17/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | IPSC | Buy Now | Century Therapeutics | $2.50 | 540% | → $16 | Maintains | Buy | Get Alert |
| 04/17/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Maintains | Buy | Get Alert |
| 04/17/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Maintains | Buy | Get Alert |
| 04/17/2023 | INAB | Buy Now | IN8bio | $0.83 | 861.31% | → $8 | Maintains | Buy | Get Alert |
| 04/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 38.53% | → $75 | Reiterates | → Buy | Get Alert |
| 04/14/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Maintains | Buy | Get Alert |
| 04/11/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 38.53% | → $75 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | INAB | Buy Now | IN8bio | $0.83 | 861.31% | → $8 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | GTBP | Buy Now | GT Biopharma | $2.68 | -25.37% | → $60 | Reiterates | → Hold | Get Alert |
| 03/30/2023 | BCEL | Buy Now | Atreca | $0.09 | 11011.11% | → $10 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | INAB | Buy Now | IN8bio | $0.83 | 861.31% | → $8 | Initiates | → Buy | Get Alert |
| 03/24/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | → $2 | Reiterates | → Hold | Get Alert |
| 03/16/2023 | IPSC | Buy Now | Century Therapeutics | $2.50 | 540% | → $16 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | CVM | Buy Now | CEL-SCI | $1.16 | 762.07% | → $10 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 543.78% | → $15 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | FATE | Buy Now | Fate Therapeutics | $3.28 | 204.88% | → $10 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.55 | 167.64% | → $55 | Reiterates | → Buy | Get Alert |
| 02/22/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 38.53% | → $75 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | CVM | Buy Now | CEL-SCI | $1.16 | 762.07% | → $10 | Assumes | → Buy | Get Alert |
| 02/15/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.55 | 167.64% | → $55 | Reiterates | → Buy | Get Alert |
| 02/14/2023 | ARAV | Buy Now | Aravive | — | — | → $10 | Maintains | Buy | Get Alert |
| 02/13/2023 | GTHX | Buy Now | G1 Therapeutics | $2.35 | 708.51% | $35 → $19 | Maintains | Buy | Get Alert |
| 01/06/2023 | IPSC | Buy Now | Century Therapeutics | $2.50 | 540% | $18 → $16 | Maintains | Buy | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $3.28 | 204.88% | $16 → $10 | Maintains | Buy | Get Alert |
| 01/05/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.99 | 910% | → $10 | Initiates | → Buy | Get Alert |
| 01/05/2023 | IPSC | Buy Now | Century Therapeutics | $2.50 | 620% | → $18 | Initiates | → Buy | Get Alert |
| 01/05/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Initiates | → Buy | Get Alert |
| 01/05/2023 | BCAB | Buy Now | BioAtla | $1.37 | 1724.82% | → $25 | Initiates | → Buy | Get Alert |
| 01/05/2023 | ATRA | Buy Now | Atara Biotherapeutics | $8.50 | 194.12% | → $625 | Initiates | → Buy | Get Alert |
| 01/05/2023 | MRUS | Buy Now | Merus | $59.17 | -40.85% | → $35 | Initiates | → Buy | Get Alert |
| 01/05/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 543.78% | → $15 | Initiates | → Buy | Get Alert |
| 01/05/2023 | BCYC | Buy Now | Bicycle Therapeutics | $20.55 | 167.64% | → $55 | Initiates | → Buy | Get Alert |
| 01/05/2023 | GTHX | Buy Now | G1 Therapeutics | $2.35 | 1389.36% | → $35 | Initiates | → Buy | Get Alert |
| 01/05/2023 | SVA | Buy Now | Sernova | $5.85 | -14.53% | → $5 | Initiates | → Buy | Get Alert |
| 01/05/2023 | GNTA | Buy Now | Genenta Science | $3.10 | 383.87% | → $15 | Initiates | → Buy | Get Alert |
| 01/05/2023 | CGEN | Buy Now | Compugen | $1.78 | 630.34% | → $13 | Initiates | → Buy | Get Alert |
| 01/05/2023 | REPL | Buy Now | Replimune Group | $9.00 | 566.67% | → $60 | Initiates | → Buy | Get Alert |
| 01/05/2023 | FATE | Buy Now | Fate Therapeutics | $3.28 | 387.8% | → $16 | Initiates | → Buy | Get Alert |
| 01/05/2023 | CRSP | Buy Now | CRISPR Therapeutics | $54.14 | 38.53% | → $75 | Initiates | → Buy | Get Alert |
| 01/05/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | → $2 | Initiates | → Hold | Get Alert |
| 01/05/2023 | GTBP | Buy Now | GT Biopharma | $2.68 | -25.37% | → $60 | Initiates | → Hold | Get Alert |
| 01/05/2023 | BCEL | Buy Now | Atreca | $0.09 | 11011.11% | → $10 | Initiates | → Buy | Get Alert |
| 01/05/2023 | APGN | Buy Now | Apexigen | — | — | → $8 | Initiates | → Buy | Get Alert |
| 10/20/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | $14 → $0.55 | Downgrade | Buy → Sell | Get Alert |
| 07/13/2022 | HGEN | Buy Now | Humanigen | $0.00 | 999900% | $13 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 06/02/2022 | RAIN | Buy Now | Rain Oncology | — | — | → $16 | Initiates | → Buy | Get Alert |
| 02/17/2022 | MRKR | Buy Now | Marker Therapeutics | $5.21 | -80.81% | $30 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 11/19/2021 | CMPX | Buy Now | Compass Therapeutics | $1.04 | 1342.31% | — | Initiates | → Buy | Get Alert |
| 08/04/2021 | TBIO | Buy Now | Telesis Bio | $3.47 | 995.1% | $810 → $684 | Maintains | Neutral | Get Alert |
| 07/26/2021 | TBIO | Buy Now | Telesis Bio | $3.47 | 1196.83% | $504 → $810 | Maintains | Buy | Get Alert |
| 06/28/2021 | PBLA | Buy Now | Panbela Therapeutics | $0.40 | 2400% | → $240000 | Initiates | → Buy | Get Alert |
| 03/18/2021 | TBIO | Buy Now | Telesis Bio | $3.47 | 706.92% | $666 → $504 | Maintains | Buy | Get Alert |
| 03/17/2021 | GTBP | Buy Now | GT Biopharma | $2.68 | 832.84% | → $750 | Initiates | → Buy | Get Alert |
| 06/18/2019 | TBIO | Buy Now | Telesis Bio | $3.47 | 620.46% | → $450 | Initiates | → Buy | Get Alert |
